Copy of `AGNIC - Wildlife terms`
The wordlist doesn't exist anymore, or, the website doesn't exist anymore. On this page you can find a copy of the original information. The information may have been taken offline because it is outdated.
|
|
AGNIC - Wildlife terms
Category: Animals and Nature > Wildlife Management
Date & country: 27/09/2013, USA Words: 917
|
parenteralnutrients given by injection into a vein, bypassing the gastrointestinal tract.
pathogen (adjective pathogenic)any disease-causing agent, especially a microorganism (bacteria, virus, fungus, parasite).
pathogenesisthe development and progression of a disease.
pathology (adjective pathologic)the study of disease, including the causes, development, and progression of disease, and how the body is affected.
pcrsee polymerase chain reaction.
peak levelthe highest level of drug reached in the body after a dose is taken. Contrast with trough level.
peer reviewa review of the scientific merit of a clinical trial by independent experts.
peg-intronbrand name of pegylated interferon-alpha-2b, produced by Schering-Plough.
pegasysbrand name of pegylated interferon-alpha-2a, produced by Genentech Inc.
peginterferonsee pegylated interferon.
pegylationa process in which polyethylene glycol (PEG) molecules are attached to proteins in order to extend their activity in the body.
peisee percutaneous ethanol injection.
percutaneousthrough the skin.
percutaneous ethanol injectiona treatment for hepatocellular carcinoma in which ethanol (alcohol) is injected into the tumor.
perihepatitisinflammation of the lining of the liver.
perinatalthe period around the time of birth.
perinatal transmissionsee vertical transmission.
peripheral neuropathydamage to the peripheral nerves, usually involving the feet and hands.
peritoneumthe thick membrane that lines the abdominal cavity and covers the visceral organs.
peritonitisinflammation of the peritoneum.
pernicious anemiaa type of anemia caused by the inability of the intestine to absorb vitamin B12, which is needed to produce red blood cells.
phagocytea scavenger cell that engulfs and destroys invading pathogens (phagocytosis).
pharmaceuticalhaving to do with the development and manufacture of drugs, or to a manufactured drug.
pharmacokineticsthe action of drugs in the body, including the processes of absorption, metabolism, distribution to tissues, and elimination.
pharmacologythe science of drugs, their sources, and how they work.
phase i trialthe first stage of human testing of a new treatment. Phase I trials evaluate drug pharmacokinetics, safety, and toxicity at different dose levels, typically in a small number of healthy volunteers or in those who have the condition or disease.
phase ii trialthe second stage of the evaluation of a new treatment in humans. Phase II trials evaluate safety and preliminary efficacy in a larger number of participants than Phase I studies.
phase iii trialthe third stage of human testing of an experimental treatment. Phase III trials are designed to determine the safety and efficacy of a treatment, often by comparing it to an existing standard therapy or a placebo.
phlebotomywithdrawal of blood from a vein.
photosensitivityan increased sensitivity to light, which may lead to easy sunburning and other adverse effects.
phyllanthustropical plant species that traditionally have been used to treat liver conditions.
pigmenta substance responsible for the color of bodily tissues.
placeboan inert, inactive agent (e.g., pill, injection) that has no treatment value.
placebo armthe group of participants in a clinical trial that receives an inactive substance (placebo).
placebo effecta change in symptoms or disease progression associated with the treatment process itself, rather than the actual therapeutic value of a treatment.
placebo-controlled triala clinical trial in which a group receiving an inactive substance or mock therapy (placebo) is compared to a group receiving the experimental treatment.
placentathe organ that connects the fetus and the mother's uterus and enables the exchange of oxygen, nutrients, and waste products.
plasmathe fluid, non-cellular portion of circulating blood. See also serum.
plasmapheresisa procedure in which certain components are removed from the blood plasma.
plateletsee thrombocyte.
platelet countThe number of platelets in the blood. People with advanced liver disease may have reduced platelet counts, resulting in easy bleeding. A normal platelet count is 130,000-400,000/mcl.
pneumonitislung inflammation.
potaken by mouth.
polymerase chain reaction (pcr)a highly sensitive test that uses an amplification technique to detect small amounts of genetic material (DNA or RNA) in a blood or tissue sample.
polymerase inhibitoran agent that inhibits viral replication by interfering with the polymerase enzyme.
porphyria cutanea tardaa condition in which porphyrins build up in the body leading to symptoms including increased photosensitivity, skin damage, and discoloration.
porphyrina metabolic byproduct of hemoglobin production.
portal hypertensionhigh blood pressure in the portal vein that carries blood to the liver, caused by the development of fibrous scar tissue (cirrhosis) in the liver.
portal systema series of veins from the small and large intestines, stomach, and spleen that join into the portal vein and are carried into the liver.
portal veinthe blood vessel that carries oxygen-poor blood from the intestines to the liver for filtering.
post-marketing studysee Phase IV trial.
postnatal (postpartum)the period following birth.
potassiuman element and electrolyte responsible for the body
powera statistical term used to describe the ability of a clinical trial to detect a particular result. Generally the power of a study increases as more participants are included or as the trial continues for a longer period of time.
pranain Ayurveda, the body's vital energy.
preclinical researchlaboratory and animal studies on an experimental treatment prior to clinical trials in humans.
prenatalthe period preceding birth, during which the fetus develops in the uterus.
prevalence (also prevalence rate)the number of individuals with a condition in a specific population. The prevalence rate is determined by dividing the number of people with the condition by the total population. Contrast with incidence.
primary care physiciana physician who is responsible for the overall long term health maintenance of a patient.
principle investigatorthe chief researcher conducting a clinical trial.
prior partial-respondera person who has a 2 log10 drop in HCV RNA by treatment week 12, but who does not become HCV RNA negative by end of treatment. (Example 2 log10 drop
procritsee erythropoietin.
prodruga compound that is converted to an active drug within the body.
progesteronea female hormone with anti-estrogen effects. Progesterone prepares the uterus for the development of the fertilized ovum and maintains the uterus throughout pregnancy.
prognosis (adjective prognostic)a forecast of the probable course or outcome of a disease.
progressiondevelopment of a disease over time.
prokinesee granulocyte colony-stimulating factor.
prophylaxisa measure taken to prevent a disease or condition.
prospective studya clinical trial in which participants are selected and their progression is followed over time. Contrast with retrospective study.
protease inhibitoran agent that inhibits viral replication by interfering with the virus' protease enzyme. HCV protease inhibitors include boceprevir and telaprevir.
proteina complex organic compound consisting of a sequence of amino acids folded in a specific configuration. Proteins are major components of living cells and are essential for bodily growth and repair.
prothrombina protein synthesized by the liver that is necessary for proper blood clotting.
prothrombin time (pt)a measure of blood clotting time. People with advanced liver disease may have a slower than normal PT. A normal PT is 10-12 seconds.
protocola written plan for a clinical trial, which typically includes details such as the hypothesis to be tested, who can participate, length of the trial, how the treatment under study will be administered, endpoints, and potential risks and benefits.
pruritus (adjective pruritic)itchiness.
psoriasisa skin condition characterized by scaling and red patches, due to the overproduction of skin cells.
psoriatic arthritisa form of rheumatoid arthritis associated with psoriasis.
psychosisa serious mental illness.
psychosociala term used to refer to factors that affect the psychological or social realm. Psychosocial factors (e.g., socioeconomic status, education, family situation) can have an important effect on disease risk and progression and are an essential aspect of a person's well-being.
psychotherapytreatment of mental problems with non-medical therapies, in particular counseling.
psychotropica drug that affects psychological or mental functioning or behavior.
ptpatient.
pulmonary fibrosisthe development of fibrous tissue in the lungs.
purpurasee thrombocytopenic purpura.
purulentcharacterized by the accumulation of pus.
pusa thick, greenish-yellow fluid composed of dead white blood cells, killed microorganisms, and other cellular debris.
pyrrolizidine alkaloida hepatotoxic component found in plants of the Crotalaria, Senecio, and Heliotropium families.
qi (chi)the vital energy believed to be responsible for health and disease in traditional Chinese medicine.
qigonga form of traditional Chinese exercise that promotes the healthy flow of qi.
qualitativerelating to, or expressed in terms of, quality. A qualitative viral load test measures the presence of a virus.
quality of life study (qol)a clinical trial that measures how a condition affects the daily life of a person with a chronic illness. A clinical trial of an investigational medication may have a quality of life component to find out the effects of the study drug on QOL and if successful treatment improves QOL.
quantitativerelating to, or expressed in terms of, quantity. A quantitative viral load test measures the amount of viral genetic material.
quasispeciesindividual genetic variants of HCV. Within a single genotype there may be multiple quasispecies.
rasee rheumatoid arthritis.
radiation therapy (radiotherapy)the use of radiation to treat disease (especially cancer).
radiographythe use of X-ray pictures, for example for diagnosis.
radiologista physician who uses x-rays or other imaging procedures for diagnosis and treatment.
randomized triala clinical trial arranged to produce a chance distribution of participants into different arms (e.g., experimental treatment, standard treatment, or placebo). Clinical trial participants are usually randomized by computer to prevent potential bias of investigators. Randomization is done to minimize bias.
rapid virological response (rvr)HCV RNA negative at treatment week 4.
raynaud's phenomenontemporary interruption of blood flow to the extremities (fingers, toes, tip of nose and ears), often associated with exposure to cold temperatures.